Leadership, Planning and Evaluation

项目概要/摘要 领导、规划和评估 执行董事Suresh Ramalingam博士为Winship提供整体战略方向，并监督 严格的规划和评估过程。Ramalingam建立了一个强大的领导团队， 作为值得信赖的顾问和领导者，支持Winship战略目标的发展和实现。 在本供资期间，该小组已扩大到包括社区外展的主要专家， 参与（COE），多样性，公平和包容（DEI）以及培训和教育（CRTEC）。关于Winship 执行团队现由执行主任、副主任、五名协理主任、一名主任 多样性官员，五名高级顾问，两个在逃职位。领导团队共同领导了 Winship的研究计划，共享资源，临床研究和临床运营的持续增长。 通过Winship的战略计划实施的持续规划和评估工作促进了 随着基础癌症研究项目数量的增加，整个癌症研究企业的增长 转化为制药商发起的临床试验，增加临床试验入组， 格鲁吉亚集水区，并通过成功的计划拨款申请扩大团队科学 包括肺孢子、P01和骨髓瘤SCOR奖。Winship由内部和外部专家指导 包括一个外部顾问委员会（EAB），由一群著名的癌症中心主任组成， 来自全国其他NCI指定癌症中心的项目负责人、研究人员和管理人员。 EAB负责对Winship的进展进行持续的关键评估，并指导 制定和实施战略计划。EAB每年在Winship举行会议， Winship的进展、计划和重大决策。此外，Winship还邀请EAB成员就以下问题提供意见： 一年中的重大决策和重大问题。

PROJECT SUMMARY/ABSTRACT LEADERSHIP, PLANNING, AND EVALUATION Executive Director Suresh Ramalingam, MD, provides the overall strategic direction for Winship and oversees a rigorous planning and evaluation process. Ramalingam established a strong leadership team whose members serve as trusted advisors and leaders to support the development and achievement of Winship's strategic goals. During the current funding period, this team has expanded to include key experts for community outreach and engagement (COE), diversity, equity, and inclusion (DEI), and training and education (CRTEC). The Winship executive team is now composed of the Executive Director, Deputy Director, five associate directors, a Chief Diversity Officer, five senior advisors, and two at-large positions. Together the leadership team has led the continued growth in Winship's research programs, shared resources, clinical research, and clinical operations. Continuous planning and evaluation efforts as implemented through Winship's Strategic Plan have fostered growth across the cancer research enterprise with increasing numbers of basic cancer research projects translating into investigator-initiated clinical trials, increased clinical trials enrollment supporting the state of Georgia catchment area, and expansion of team science with successful programmatic grant submissions including lung SPORE, P01, and a myeloma SCOR award. Winship is guided by internal and external experts including an External Advisory Board (EAB), which is composed of a renowned group of cancer center directors, program leaders, researchers, and administrators from other NCI-designated cancer centers across the country. The EAB is charged to provide critical evaluation of Winship's progress on an ongoing basis and guide the development and implementation of the strategic plan. The EAB meets annually at Winship to review and critique Winship's progress, plans, and major decisions. In addition, Winship also engages EAB members for input on important topics and key decisions throughout the year.